Back
to sessions
Sep 28
Scientific
MODERATOR(S)
Jolinta Lin, MD - Emory University School of Medicine
Shane Lloyd, MD - University of Utah
Credits
| AMA PRA Category 1 Credits: | 1.00 |
Presentations
-
05:00pm - 05:10pm ETSpeaker: Jordan Kharofa, MD - University of Cincinnati, Cincinnati
-
05:10pm - 05:20pm ET
Quality Assurance Analysis of EA2182 Supports Pretreatment Radiation Plan Review in Anal Cancer Clinical Trials
Speaker: Joshua Meyer, MD, FASTRO - Fox Chase Cancer Center, Philadelphia -
05:20pm - 05:30pm ET
Circulating Tumor DNA Positivity after Chemoradiation Marks an Imminent High-Risk State in Anal Squamous Cell Carcinoma
Speaker: Elisa Liu, MD, BS - Memorial Sloan Kettering Cancer Center, New York -
05:30pm - 05:40pm ETSpeaker: Ann Raldow, MD, MPH - UCLA David Geffen School of Medicine/UCLA Medical Center, Los Angeles
-
05:40pm - 05:50pm ETSpeaker: Leila Tchelebi, MD - Northwell Health, Lake Success
-
05:50pm - 06:00pm ET
Pathological Complete Response and ctDNA Analyses Results from a Randomized Phase III Trial of Neoadjuvant Chemotherapy or Chemoradiotherapy plus Sintilimab vs. Chemoradiotherapy in Resectable Locally Advanced Esophageal Squamous Cell Carcinoma
Speaker: Jiahua Lv, MD, PhD - Sichuan Cancer Hospital and Institute, chengdu